A pilot study examining molecular and clinical effects of aromatase inhibitor therapy on skeletal muscle function in early stage breast cancer
This research is being done to study how a type of breast cancer medicine called aromatase inhibitors (AI) affect muscle function in patients with breast cancer
The purpose of this study is to learn more about the effects that aromatase inhibitors have on muscle function in patients with breast cancer.
Participants will be compensated for their participation.
- IRB Number: 1801852430 (IUSCC-0647)
- Research Study Identifier: TX8793
- Principal Investigator: Tarah Ballinger, MD
Contact the research team to learn more about this study.
Fields marked with asterisk (*) are required